Ana Comin

ORCID: 0009-0008-6211-187X · 2 papers in corpus

other 2025

Rationale and design of the GLADE study: a randomized, multicenter, double-blind, placebo-controlled trial evaluating the safety and efficacy of gestrinone subdermal bioabsorbable pellet in endometriosis-related pelvic pain

Annals of medicine ·doi:10.1080/07853890.2025.2527352

BACKGROUND: Pelvic pain secondary to endometriosis is a disabling condition. There are multiple treatments available, with variable endpoints. No prospective controlled studies were carried out evaluating subdermal pellets of gestrinone in …

review 2025

Tolerability and Shared Decision-Making in the Hormonal Management of Endometriosis-Associated Pain

Biomedicines ·doi:10.3390/biomedicines13092294

Background: The management of endometriosis-associated pain has traditionally focused on analgesic efficacy. However, with high-level evidence demonstrating therapeutic equivalence among principal hormonal classes, the paradigm has shifted …